Intravenous fluconazole is used in the treatment of fungal infections in in
fants. Little is known, however, about the pharmacokinetics of fluconazole
after oral administration in premature infants. Oral fluconazole was admini
stered at a dose of 6 mg/kg. The peak serum concentration (C-max), area und
er the serum concentration-time curve (AUC), and apparent clearance ranged
from 6.0-13.5 mu g/ml, 340-636 mu g.h/ml, and 0.16-0.29 ml/min/kg, respecti
vely. The C-max and AUC were comparable after oral and intravenous doses of
fluconazole. Oral fluconazole was well absorbed and tolerated. The use of
oral fluconazole may offer an important alternative to the intravenous ther
apy; it may improve patient convenience, reduce the need for venous access
and decrease complications and the cost of hearth care.